---
title: "BAO LIN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e8bc53b5-8979-51ce-8dff-1d72cfd50337
json: https://whiteintel.dev/api/public/dossier/e8bc53b5-8979-51ce-8dff-1d72cfd50337
identifier: sec:0001941128
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BAO LIN

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001941128`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e8bc53b5-8979-51ce-8dff-1d72cfd50337  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e8bc53b5-8979-51ce-8dff-1d72cfd50337  

## Ownership & control

### Holdings / subsidiaries

- **Aimei Health Technology Co., Ltd.** (director) — https://whiteintel.dev/entity/7963d8c2-c7cf-557e-a08c-973c21d9ac22
- **CETUS CAPITAL ACQUISITION CORP.** (director) — https://whiteintel.dev/entity/13ca1336-6f37-5ed6-a48b-bb302ba482ba

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BAO LIN**. Human view: https://whiteintel.dev/entity/e8bc53b5-8979-51ce-8dff-1d72cfd50337 · Structured JSON: https://whiteintel.dev/api/public/dossier/e8bc53b5-8979-51ce-8dff-1d72cfd50337._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._